Maria Fontanazza

Outcomes LLC, publisher of market-leading Med Ad News magazine and PharmaLive.com for the life sciences industry, strengthens its leadership team with the addition of Director of Content, Maria Fontanazza. Maria adds more than 20 years of experience in journalism, marketing, and communications. She was previously Editor-in-Chief at Innovative Publishing Company Inc., covering medical devices and additional FDA-regulated markets.

Two life sciences powerhouses are coming together to develop an off-the-shelf beta cell replacement therapy for insulin-dependent diabetes patients, which they hope will become a functional cure for both types of the disease.

Leading life sciences venture firm Sofinnova Partners entered into a long-term strategic and financial partnership with Apollo, a high-growth, alternative asset manager looking to expand its presence in the life sciences.

Arcadia, a leading data analytics platform for healthcare and life sciences, and Datavant, a leader in helping organizations securely connect health data, announced a partnership to enable de-identified connectivity of Arcadia’s electronic health record data for life sciences research and commercial analytics.

EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, and Vector Pharma FZCO of Dubai UAE, the leading full-service distributor for rare disease, oncology and highly specialized therapeutics in the Middle East, North Africa and Turkish markets, announced a strategic partnership to expand services across the Middle East and North African markets.

Eversana

EVERSANA, a pioneer of next generation commercial services to the global life sciences industry, opened a new office in the heart of London’s Holborn district to serve the company’s growing client and team needs.

VERO Biotech Inc. – an Atlanta, Georgia-based company focused on saving lives, alleviating suffering, and improving the health economics of care – was awarded the prestigious Golden Helix “Innovation Award” for its breakthrough development of the GENOSYL® Delivery System, the first advancement in the delivery of inhaled nitric oxide in 20 years, and the “Deal of the Year” Award for 2022 by Georgia Bio, the state’s life science trade association.

The FDA issued new guidance, titled “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Subgroups in Clinical Trials,” that calls for companies to submit a Race and Ethnicity Diversity Plan to include more underrepresented minority populations in the United States.

EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, and UpScriptHealth, a leading telehealth and virtual prescribing platform serving life sciences companies, announced a strategic partnership to create a direct-to-patient platform that will transform the patient experience to help accelerate access to therapies worldwide.

Global health innovation company Real Chemistry announced the acquisition of conversationHEALTH, a conversational artificial intelligence (AI) platform for the health care and life sciences industry.